Seasoned investor and operator focused on growth-stage technology and healthcare opportunities, known for sourcing cross-border deals, driving operational improvements, and executing liquidity events. Paul Cohen brings experience across private equity, venture capital and operating roles, advising management teams on commercial strategy, go-to-market scaling and capital structure. Regular board director and active portfolio manager, prioritizes data-driven KPIs, margin expansion and disciplined M&A to create enterprise value for institutional investors.
Seasoned investor and operator focused on growth-stage technology and healthcare opportunities, known for sourcing cross-border deals, driving operational improvements, and executing liquidity events. Paul Cohen brings experience across private equity, venture capital and operating roles, advising management teams on commercial strategy, go-to-market scaling and capital structure. Regular board director and active portfolio manager, prioritizes data-driven KPIs, margin expansion and disciplined M&A to create enterprise value for institutional investors.
Focuses on growth-stage technology and healthcare companies, deploying capital with a hands-on, operationally driven approach that prioritizes data‑driven KPIs, margin expansion and scalable go‑to‑market playbooks. Prefers cross‑border and complex capital structures where disciplined M&A and active board involvement accelerate exits. Time horizon is growth-to-liquidity, balancing aggressive scaling with staged capital tranches, clear operational milestones and downside protection through conservative covenants and portfolio diversification.
Focuses on growth-stage technology and healthcare companies, deploying capital with a hands-on, operationally driven approach that prioritizes data‑driven KPIs, margin expansion and scalable go‑to‑market playbooks. Prefers cross‑border and complex capital structures where disciplined M&A and active board involvement accelerate exits. Time horizon is growth-to-liquidity, balancing aggressive scaling with staged capital tranches, clear operational milestones and downside protection through conservative covenants and portfolio diversification.
| Trades 249 | Longs Won 156/249 62% | Profit Factor 21.05 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $2.76M |
| Average Win $396,877.27 | Best Trade (Oct 14) $45.2M | Sharpe Ratio -11.64 |
| Average Loss -$31,633.23 | Worst Trade (Mar 31) -$414,750.71 | Z-Score 6.51 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3d | Expectancy $236,831.18 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% | 0.15% | 1.09% | 5.91% | 26.31% |
| Consecutive Losing Trades | 6,494 | 5,844 | 5,195 | 4,545 | 3,896 | 3,247 | 2,597 | 1,948 | 1,299 | 649 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 27,270 | $5.54M | $9.33M | - | $3.8M | 68.55% | +0.07% |
AMZN Amazon.com Inc | 12,719 | $2.62M | $3.18M | - | $553,147.48 | 21.08% | -1.959% |
AVGO Broadcom Inc. | 1,223 | $403,709.51 | $404,470.56 | - | $761.05 | 0.19% | -3.953% |
AXP American Express Company | 2,180 | $631,735.14 | $682,819.6 | - | $51,084.46 | 8.09% | -0.207% |
BINC iShares Flexible Income Active ETF | 209,104 | $11.07M | $10.6M | - | -$469,886.57 | -4.25% | -0.01% |
BLK BlackRock, Inc. | 566 | $658,704.52 | $637,423.54 | - | -$21,280.98 | -3.23% | +0.483% |
C Citigroup Inc. | 1,453 | $203,435 | $180,135.67 | - | -$23,299.33 | -11.45% | +0.621% |
CSCO Cisco Systems, Inc. | 5,895 | $408,039.19 | $635,068.35 | - | $227,029.16 | 55.64% | -1.93% |
GEV GE Vernova Inc. | 312 | $272,350 | $288,718.56 | - | $16,368.56 | 6.01% | -0.114% |
GOOG Alphabet Inc | 4,673 | $1.47M | $1.57M | - | $100,169.81 | 6.79% | -2.317% |
GS The Goldman Sachs Group, Inc. | 4,053 | $2.03M | $3.56M | - | $1.53M | 75.56% | -1.388% |
HOOD Robinhood Markets, Inc. | 2,912 | $397,612.34 | $286,366.08 | - | -$111,246.26 | -27.98% | -5.433% |
HOWL Werewolf Therapeutics, Inc. | 10,870 | $3,347.96 | $10,734.12 | - | $7,386.16 | 220.62% | -0.953% |
JPM JPMorgan Chase & Co. | 22,050 | $4.43M | $7.47M | - | $3.04M | 68.66% | +1.019% |
KO The Coca-Cola Company | 3,305 | $268,662 | $307,695.5 | - | $39,033.5 | 14.53% | +1.196% |
META Meta Platforms Inc Class A | 5,227 | $2.26M | $3.69M | - | $1.43M | 63.27% | -4.278% |
MS Morgan Stanley | 2,450 | $403,783.91 | $443,058 | - | $39,274.09 | 9.73% | -0.692% |
MSFT Microsoft Corp. | 9,811 | $3.79M | $5.17M | - | $1.38M | 36.32% | -2.386% |
MSGS Madison Square Garden Sports Corp. | 3,115 | $896,851.15 | $1.22M | - | $321,082.7 | 35.8% | -3.378% |
NVDA NVIDIA Corporation | 3,196 | $295,588.37 | $685,446.12 | - | $389,857.75 | 131.89% | -1.271% |